Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Oct 21, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the relationship between obstructive sleep apnea (OSA) and multiple sclerosis (MS). Sleep apnea is a condition that causes breathing problems during sleep, which can lead to low oxygen levels. Researchers want to understand how this condition might affect people with MS, particularly looking at how it relates to MRI scans and other clinical data. They will collect information from MS patients, including medical history and sleep studies, to see if there are any links between the severity of MS symptoms and the presence of sleep apnea.

To participate in this study, individuals need to be over 18 years old and have a confirmed diagnosis of multiple sclerosis. They must also be able to give written consent to join the trial. Participants will undergo various assessments, including sleep studies and MRI scans, to help researchers gather important information about how sleep apnea may impact MS. This research aims to improve our understanding of both conditions and potentially guide better patient care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Written consent
• • Over age 18
• • Confirmed diagnosis of multiple sclerosis
• Exclusion Criteria:
• • cannot provide informed consent